A Crowd Sourcing Platform for Patients With Cancer
NCT03530826 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2024-07-30
Summary
All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.
Conditions
Interventions
- OTHER
-
No intervention
No Intervention
Sponsors & Collaborators
-
All4Cure
lead INDUSTRY
Principal Investigators
-
Carl A Blau, MD · All4Cure
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-26
- Primary Completion
- 2028-01-31
- Completion
- 2028-01-31
Countries
- United States
Study Locations
More Related Trials
-
Combined Modality Treatment for Patients With Stage IV Melanoma
NCT00313235 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00053391 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00004184 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer
NCT00704938 ·Status: TERMINATED ·Phase: PHASE2
-
Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00003646 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
NCT00722228 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma
NCT00074230 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of GC101 TIL in Advanced Melanoma
NCT06703398 ·Status: RECRUITING ·Phase: PHASE2
-
Vaccine Therapy in Treating Patients With Melanoma
NCT00003556 ·Status: COMPLETED ·Phase: PHASE1
-
MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer
NCT04082182 ·Status: UNKNOWN ·Phase: PHASE1
-
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive
NCT02153905 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery
NCT01989559 ·Status: COMPLETED ·Phase: PHASE1
-
Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma
NCT00610311 ·Status: TERMINATED ·Phase: PHASE2
-
CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
NCT00090896 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma
NCT01026051 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma (ASET)
NCT01265368 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multiepitope Peptide Vaccination in Melanoma
NCT00153569 ·Status: UNKNOWN ·Phase: PHASE2
-
Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma
NCT01339663 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors
NCT01946789 ·Status: COMPLETED ·Phase: PHASE1
-
Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
NCT00004022 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma
NCT00082459 ·Status: TERMINATED ·Phase: PHASE2
-
Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma
NCT00010309 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Biological Therapy in Treating Patients With Metastatic Melanoma
NCT00002786 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum
NCT01313429 ·Status: TERMINATED ·Phase: PHASE1
-
Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer
NCT00003023 ·Status: COMPLETED ·Phase: PHASE1